Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy AEON Biopharma stock (AEON Biopharma)

Learn how to buy AEON Biopharma stock in 5 easy steps.

AEON Biopharma postponed its planned initial public offering as the stock market volatility continues to impact the IPO landscape.

We'll update this page as new information becomes available.

Our top picks for where to buy AEON Biopharma stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy AEON Biopharma stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – AEON. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy AEON Biopharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AEON Biopharma stock price (NYSE MKT: AEON)

Use our graph to track the performance of AEON stocks over time.

AEON Biopharma shares at a glance

Information last updated 2024-12-19.
Latest market close$0.60
52-week range$0.52 - $17.17
50-day moving average $0.81
200-day moving average $2.81
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.14

Is it a good time to buy AEON Biopharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AEON Biopharma price performance over time

Historical closes compared with the close of $0.65 from 2024-12-20

1 week (2024-12-17) 0.65
1 month (2024-11-22) 22.62%
3 months (2024-09-24) -11.07%
6 months (2024-06-24) -35.64%
1 year (2023-12-22) -88.70%
2 years (2022-12-23) -93.51%
3 years (2021-12-23) 9.72
5 years (2019-12-20) N/A

AEON Biopharma financials

Gross profit TTM $0
Return on assets TTM -597.69%
Return on equity TTM 0%
Profit margin 0%
Book value $-4.12
Market Capitalization $26.6 million

TTM: trailing 12 months

AEON Biopharma share dividends

We're not expecting AEON Biopharma to pay a dividend over the next 12 months.

You may also wish to consider:

AEON Biopharma share price volatility

Over the last 12 months, AEON Biopharma's shares have ranged in value from as little as $0.5206 up to $17.17. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while AEON Biopharma's is 0.397. This would suggest that AEON Biopharma's shares are less volatile than average (for this exchange).

To put AEON Biopharma's beta into context you can compare it against those of similar companies.

AEON Biopharma overview

AEON Biopharma, Inc. , a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California. .

Frequently asked questions

null
What percentage of AEON Biopharma is owned by insiders or institutions?
Currently 36.231% of AEON Biopharma shares are held by insiders and 33.143% by institutions.
How many people work for AEON Biopharma?
Latest data suggests 5 work at AEON Biopharma.
When does the fiscal year end for AEON Biopharma?
AEON Biopharma's fiscal year ends in December.
Where is AEON Biopharma based?
AEON Biopharma's address is: 5 Park Plaza, Irvine, CA, United States, 92614
What is AEON Biopharma's ISIN number?
AEON Biopharma's international securities identification number is: US00775E1029

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site